NCT07647861

Brief Summary

Dentine hypersensitivity is a common clinical problem. Although Nd:YAG lasers, diode lasers, and topical desensitizing agents are widely utilized, long-term comparative evidence regarding their clinical efficacy remains limited. This prospective, randomized, parallel-arm, evaluator-blind, sham-controlled clinical trial evaluated and compared the 12-month clinical performance of an Nd:YAG laser, a diode laser, a herbal propolis-based dentin barrier agent, and a sham application.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 15, 2025

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

June 10, 2026

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 10, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 10, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 15, 2026

Completed
Last Updated

June 15, 2026

Status Verified

June 1, 2026

Enrollment Period

6 months

First QC Date

June 10, 2026

Last Update Submit

June 10, 2026

Conditions

Keywords

Dentine HypersensitivityNd:YAG LaserDiode LaserPropolisLasers in DentistryDentin Desensitizing Agents

Outcome Measures

Primary Outcomes (1)

  • Change in Visual Analog Scale (VAS) Score after Air Stimulus

    Pain intensity evaluated using the Visual Analog Scale (VAS), where scores range from 0 (no pain) to 10 (extreme/worst pain). The primary outcome is defined as the change in pain intensity in response to a controlled air blast stimulus from baseline to 6 months.

    Baseline and 6 months

Secondary Outcomes (2)

  • Schiff Cold Air Sensitivity Scale Score

    Baseline, immediately post-treatment, 1 week, 1 month, 3 months, and 6 months

  • Tactile Sensitivity Score

    Baseline, immediately post-treatment, 1 week, 1 month, 3 months, and 6 months

Study Arms (4)

Group 1: Nd:YAG Laser

EXPERIMENTAL

Participants assigned to this group received Nd:YAG laser application targeted at the hypersensitive teeth to achieve desensitization. The procedure was completed during the treatment session according to the clinical protocol.

Device: Nd:YAG Laser Application

Group 2: Diode Laser

EXPERIMENTAL

Participants assigned to this group received Diode laser application on the affected dentine areas for hypersensitivity treatment. The application was performed in accordance with the specified parameters.

Device: Diode Laser Application

Group 3: Dentin Barrier Agent

EXPERIMENTAL

Participants assigned to this group received a topical application of a herbal propolis-based dentin barrier agent onto the hypersensitive tooth surfaces. The agent was applied to seal the dentinal tubules and reduce sensitivity.

Other: Herbal Propolis-Based Dentin Barrier Agent

Group 4: Sham Application

SHAM COMPARATOR

Participants assigned to this group received a sham (placebo) procedure designed to completely simulate the laser or topical application experience without delivering any active laser energy or therapeutic desensitizing agent. This group served as the control to account for the placebo effect.

Other: Sham Application

Interventions

Nd:YAG laser application performed for the treatment of dentine hypersensitivity.

Group 1: Nd:YAG Laser

Diode laser application performed for the treatment of dentine hypersensitivity.

Group 2: Diode Laser

Topical application of a herbal propolis-based dentin barrier agent.

Group 3: Dentin Barrier Agent

Placebo/sham procedure to simulate treatment without delivering active laser or therapeutic agent benefits

Group 4: Sham Application

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged between 18 and 65 years.
  • Presence of at least two hypersensitive teeth.
  • Visual Analog Scale (VAS) score of 4 or higher (VAS \>= 4) following stimulus.
  • Schiff Cold Air Sensitivity Scale score of 2 or higher (Schiff \>= 2).
  • Presence of vital teeth in the target area.
  • Patient is willing and able to provide written informed consent prior to study initiation.

You may not qualify if:

  • Pregnancy or lactation.
  • Presence of active periodontal disease in the target area.
  • Teeth with dental caries, deep restorations, or cracked tooth syndrome.
  • Endodontically treated teeth.
  • History of allergy or hypersensitivity related to the materials, products, or chemical agents used in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ondokuz Mayıs University, Faculty of Dentistry, Department of Periodontology

Samsun, Samsun, 55270, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Dentin Sensitivity

Condition Hierarchy (Ancestors)

Tooth DiseasesStomatognathic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A randomized, parallel-group, evaluator-blinded, sham-controlled clinical trial with four allocation arms. Eligible participants were randomly assigned to one of the four groups in a 1:1:1:1 ratio to receive a single type of intervention (Nd:YAG laser, Diode laser, herbal propolis-based dentin barrier agent, or sham application) and were followed up for a period of 6 months.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

June 10, 2026

First Posted

June 15, 2026

Study Start

December 15, 2025

Primary Completion

June 10, 2026

Study Completion

June 10, 2026

Last Updated

June 15, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared publicly to ensure patient confidentiality and compliance with the ethical committee approval, which did not include a provision for public data repository sharing.

Locations